P-6126
Science Translational Medicine | 2026
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.
DeWolf S, Siegel SJ, Schmalz J, Saber W, Albanese A, Dong J, Martens MJ, Logan B, Iovino L, Ingersoll-Ohmdahl, K, Winn, N, Chen E, Kaminski J, Neuberg D, Hebert K, Keskula P, Zavistaski J, Steinberg L, Schichter I, Katsamakis, Z, Cagnin L, Hernandez V, Warren M, Applegate K, Bar M, Chhabra S, Choi SW, Clark W, Das S, Jenq R, Jones RJ, Levine JE, Murthy H, Rashidi A, Riches M, Sandhu K, Sung AD, Larkin K, Al Malki MM, Gooptu M, Elmariah H, Alousi A, Runaas L, Shaffer B, Rezvani AR, El Jurdi N, Loren AW, Scheffey D, Sanders C, Hamadani M, Dudakov J, Bien S, Robins H, Horowitz MM, Bolanos-Meade J, Holtan SG, Bhatt AS, Perales MA, Kean L
PubMed
PMID: 42905855
CIBMTR Study #: aCTN 1801-01
